After leaving UMBC, Sheye entered the New England College of Osteopathic Medicine. He was awarded the American Federation for Aging Research (AFAR) Geriatric Medical Student Fellowship for 2006-07.

Eric is a second-year student in the graduate program in Molecular and Cell Biology at the University of Maryland, Baltimore. He is pursuing a Ph.D. under the direction of Dr. Stuart Martin, whose laboratory investigates the role of the cytoskeleton in tumor cell metastasis.  

Julia is currently a second year student at University of Maryland Dental School.

After leaving UMBC,  Gerry Barcak was a postdoctoral Research Associate with Nobel Laureate Hamilton Smith. He then joined the faculty of the Department of Biochemistry and Molecular Biology of the University of Maryland School of Medicine attained the rank of Associate Professor.

Sadly, on September 22, 2007 Gerry passed away after a courageous battle with prostate cancer.  He was the beloved husband of Dr. Carmen Salvaterra, and the loving father of Kristin and Danielle Barcak.  The first annual Gerard J. Barcak Memorial Lecture was presented on September 8, 2008 by Gerry's postdoctoral advisor and Nobel Laureate Dr. Hamilton Smith, who is currently Group Leader in Synthetic Biology and Bioenergy at the J. Craig Venter Institute.  Dr. Smith's lecture, entitled "The Quest for a Minimal Cell" will be given in Taylor Lecture Hall on the campus of the University of Maryland, Baltimore.   More ..

After graduating from UMBC, Paul continued his work on photorespiration and its affects on photo synthesis at Martin Marrietta Laboratories. He subsequently left there to form Martek Biosciences, a biotechnology company focused on using microalgae to produce high-value products. He continues to work at Martek and is also an Adjunct Professor at UMBC.

Upon completing her Ph.D., Carlise received a Cancer Research Training Fellowship and is currently a Postdoctoral Fellow in the Department of Biochemistry and Molecular Biology at the Johns Hopkins University School of Public Health.

http://www.ucdmc.ucdavis.edu/medmicro/staff/bevins.html

Kelly is currently Associate Professor of Biology at Rider University, Lawrenceville, NJ. Prior to that she conducted research as a National Science Foundation postdoctoral fellow at Scripps Institution of Oceanography, UCSD, La Jolla, Ca.

After graduating Steve received a one-year NIH Postbaccalaureate Intramural Research Training Award. In the fall of 2005 he entered the University of Maryland School of Medicine where he plans to earn his MD degree in the spring of 2009.

Roxann received a fellowship from Pfizer to pursue D.V.M./Ph.D. studies at the University of California, Davis.

Qian began her postdoctoral studies in January of 2006 in the laboratory of Dr. Jiandong Chen, who is in the Interdisciplinary Oncology Program at the H. Lee Moffitt Cancer Center, in Tampa, Florida. Qian's postdoctoral research focuses on the p53 tumor suppressor protein.

Roland is currently in the Pharmaceutical Sciences PhD program at the University of North Carolina.  He completed a double major at UMBC, also receiving a B.A. in Economics

CC followed his graduate studies by doing postdoctoral work with Roger Hanlon at the Marine Biological Laboratory, in Woods Hole (where he continues to collaborate each year) and with Richard Masland, Howard Hughes Professor at Harvard University. Since 2002 he has been an Assistant Professor at National Tsing Hua University in Taiwan.

Kori joined the Rice University/Baylor College of Medicine Medical Scientist Training Program this summer to begin her MD/PhD studies.

After working as a technician at the University of California Los Angeles, Selvin studied Ophthalmology in Philadelphia, graduating with an O.D. and M.B.A. in 2000. He is a practicing Opthalmologist in Phoenix, AZ.

Jeff went on to Duke University for graduate school and obtained his PhD in 2002. After three years of a postdoctoral fellowship at Harvard University, Jeff became an Assistant Professor at the University of Texas- Austin in the section of cell and developmental biology in the fall of 2005.

Liz is pursuing a master’s degree at the University of Alaska, Fairbanks in the laboratory of Kevin Winker.  She graduated from UMBC with a double major, also receiving a B.A. in Chemistry.

Trained as a molecular biologist, Diane Auer Jones has had successful careers as an entrepreneur, government policy maker and administrator at Princeton University. A founding director of an NSF-funded Biotechnology Institute, Diane worked as a Grant Administrator at the National Science Foundation, was a staff member for the US House of Representatives Science Committee, represented Princeton University in Washington, was Deputy Associate Director at the White House Office of Science & Technology Policy and until recently was the Assistant Secretary of Education for Post-Secondary Education. She has since left government service and is President and CEO of The Washington Campus. In addition to her work in academia and government, she was a founder of AthenaES, an environmental biotechnology company where fellow alumnus, Sheldon Broedel ’84 M.S., ’90 Ph.D., biological sciences, is chief executive and science officer.

After receiving her doctorate, Chris completed postdoctoral studies on photoreceptor cell biology with Beth Burnside at the University of California, Berkeley, and then joined the faculty at St. Josephs University in Philadelphia, where she has been since 1996.

Beatrice is a Visiting Assistant Professor at Cornell College in Iowa.

Dhanya is currently a technician with the National Institutes of Health.

Karen joined the graduate program in Evolution, Ecology and Organismal Biology at the University of California, Riverside, where she is currently pursuing her Ph.D. in the laboratory of Dr. Marlene Zuk.

Tricia followed up on her work with vision in marine mammals by taking a position with the Maryland Department of Natural Resources in Oxford, MD, where she continues to work with stranded marine animals.

Marc is now Group Leader for Advanced Technologies in the Division of Proteomics, Genetics Institute of the Novartis Research Foundation, San Diego, CA.

Mike is currently associated with the Hollins Cancer Center at the University of South Carolina. After graduating from UMBC, he went on to postdoctoral positions at California Institute of Technology and the National Institutes of Health. He was then an Assistant and Associate Professor in the Department of Surgery at the U. of Chicago before moving to USC.

Ioanna is currently in her first year of pharmacy school at the University of Maryland, Baltimore.

Susan went on to receive her Ph.D. from Johns Hopkins University in 2002, where her research with her mentor Dr. Andrew Fire, the 2006 recipient of the Nobel Prize in Medicine & Physiology, was instrumental to the development of the important RNAi paradigm. She is conducting postdoctoral research at the National Institutes of Health where her research focuses on vaccinia virus pathogenesis.

Jeff completed his PhD in the Omland lab in May 2006. He was a postdoctoral fellow at the University of Alaska, Fairbanks and was recently hired as an Assistant Professor in the Department of Biological Sciences at Wright State University in Dayton, OH.  In addition, Jeff also just received a $334,000 grant from the National Science Foundation.

Luz is currently in her second year of medical school at Drexel University in Philadelphia.  She graduated from UMBC with a double major, also receiving a B.A. in Psychology.

After completing his Ph.D., Sezai joined the faculty of the Department of Biology, Abant Izzet Baysal University, Bolu, Turkey. He is currently a member of the Department of Biology, Uludag University, Bursa, Turkey where he is a Professor.

Timothy is the Director of the Discovery Group at Osiris, a stem cell research biotechnology company in Baltimore. His work has involved developing stem cell lines that aid in repair of cardiac tissue following heart attacks.

After leaving UMBC, Timothy was a Postdoctoral Research Associate in the laboratory of Dr. John Tainor of the Scripps Institute for Research, changing fields from prokaryotic molecular biology to structural biology and X-ray crystallography and solving the structure of several key iron-containing proteins of bacteria. He is now Supervisory Research Chemist in the Department of Clinical Investigation at the Walter Reed Army Medical Center.

Following his studies at UMBC, Bradley was the Alexander Hollander Postdoctoral Fellowship at The Department of Energy at Oak Ridge National Laboratories developing mouse models for animal diseases. In 1997 he joined the faculty in the Division of Cell Biology at the University of Alabama Medical School where he is now Associate Professor. His laboratory has been instrumental in identifying genes that play a role in polycysitic kidney disease.